SLC29A1, solute carrier family 29 member 1 (Augustine blood group), 2030
N. diseases: 91; N. variants: 9
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
6 | 44234615 | downstream gene variant | C/T | snv | 0.21 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
6 | 44234615 | downstream gene variant | C/T | snv | 0.21 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.160 | 6 | 44232906 | missense variant | A/C | snv |
|
0.700 | 0 | ||||||||||||
|
1.000 | 0.160 | 6 | 44232906 | missense variant | A/C | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 0.080 | 6 | 44233520 | missense variant | A/G | snv | 8.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.700 | 0 | ||||||||||
|
0.925 | 0.120 | 6 | 44233216 | intron variant | A/G | snv | 0.36 |
|
Hemic and Lymphatic Diseases | 0.030 | 0.333 | 3 | 2015 | 2017 | |||||||
|
0.882 | 0.280 | 6 | 44228841 | intron variant | T/C | snv | 0.78 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.280 | 6 | 44228841 | intron variant | T/C | snv | 0.78 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Musculoskeletal Diseases; Male Urogenital Diseases; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.280 | 6 | 44228841 | intron variant | T/C | snv | 0.78 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.120 | 6 | 44230625 | missense variant | T/C | snv | 1.8E-02 | 1.6E-02 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.925 | 0.040 | 6 | 44224183 | intron variant | A/C | snv | 0.85 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.040 | 6 | 44224183 | intron variant | A/C | snv | 0.85 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.040 | 6 | 44226608 | intron variant | G/C | snv | 0.15 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.040 | 6 | 44226608 | intron variant | G/C | snv | 0.15 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.120 | 6 | 44233216 | intron variant | A/G | snv | 0.36 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 6 | 44233216 | intron variant | A/G | snv | 0.36 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 6 | 44228255 | intron variant | C/T | snv | 0.30 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 |